NDC 67296-1547
Furosemide 20 mg tablet
On the label: RedPharm Drug. Inc.. It's repackaged: RedPharm Drug. Inc. rebottles it from Leading Pharma, LLC's NDC 69315-116.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Leading Pharma, LLC | Fairfield, NJ, United States | Makes it | Problems found, fixed voluntarilyOct 21, 2024 · 13 inspections |
Repackaging site
- RedPharm Drug, Eden Prairie, MN, United States · repackages it
Recalls
- Mar 20, 2026 · Class II · Leading Pharma, LLC
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Lots: Lots# H03125, H03225, H03325, Exp Date: 2027/08
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Furosemide: every company that makes it
- Form
- tablet
- Strength
- 20 mg
- Approval
- ANDA ANDA077293
- On the market since
- Jan 1, 2018
- Package NDCs
67296-1547-167296-1547-367296-1547-6- Official label
- DailyMed (National Library of Medicine), updated Aug 1, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?